CHUNLI MEDICAL(688236) 搜狐财经· Sou Hu Cai Jing·2025-05-06 23:57Core Viewpoint - The stock of Chunli Medical (688236) has shown a positive trend with a closing price of 15.76 yuan, reflecting a 4.03% increase on May 6, 2025, amidst varying capital flows from different investor groups [1]. Financial Performance - Chunli Medical reported a main revenue of 230 million yuan for Q1 2025, representing a year-on-year increase of 3.6% [2]. - The net profit attributable to shareholders was 58.07 million yuan, up 5.2% year-on-year, while the net profit after deducting non-recurring gains and losses was 52.70 million yuan, increasing by 7.81% [2]. - The company has a debt ratio of 17.11% and reported investment income of 3.22 million yuan, with financial expenses of -4.17 million yuan [2]. Market Position - Chunli Medical's total market capitalization is 6.045 billion yuan, with a net asset value of 2.879 billion yuan [2]. - The company ranks 47th in total market value and 52nd in net assets within the medical device industry [2]. - The price-to-earnings ratio (P/E) stands at 26.02, significantly lower than the industry average of 52.22, placing it 33rd in the industry ranking [2]. Profitability Metrics - The gross margin for Chunli Medical is 66.69%, which is higher than the industry average of 51.09%, ranking 27th in the industry [2]. - The net profit margin is 25.25%, compared to the industry average of 10.86%, ranking 28th [2]. - The return on equity (ROE) is 2.04%, outperforming the industry average of 1.06%, ranking 43rd [2]. Investor Sentiment - In the last 90 days, 8 institutions have rated the stock, with 7 buy ratings and 1 hold rating, indicating positive investor sentiment [3]. - The average target price set by institutions over the past 90 days is 17.59 yuan [3].